Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas.
Riviere-Cazaux C, Lacey JM, Carlstrom LP, Laxen WJ, Munoz-Casabella A, Hoplin MD, Ikram S, Zubair AB, Andersen KM, Warrington AE, Decker PA, Kaufmann TJ, Campian JL, Eckel-Passow JE, Kizilbash SH, Tortorelli S, Burns TC. Riviere-Cazaux C, et al. Among authors: burns tc. Neurooncol Adv. 2023 May 11;5(1):vdad061. doi: 10.1093/noajnl/vdad061. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37313502 Free PMC article. No abstract available.
Methodological and analytical considerations for intra-operative microdialysis.
Riviere-Cazaux C, Rajani K, Rahman M, Oh J, Brown DA, White JF, Himes BT, Jusue-Torres I, Rodriguez M, Warrington AE, Kizilbash SH, Elmquist WF, Burns TC. Riviere-Cazaux C, et al. Among authors: burns tc. Fluids Barriers CNS. 2023 Dec 19;20(1):94. doi: 10.1186/s12987-023-00497-2. Fluids Barriers CNS. 2023. PMID: 38115038 Free PMC article.
B cell-based therapy produces antibodies that inhibit glioblastoma growth.
Wang S, Castro BA, Katz JL, Arrieta V, Najem H, Vazquez-Cervantes GI, Wan H, Olson IE, Hou D, Dapash M, Billingham LK, Chia TY, Wei C, Rashidi A, Platanias LC, McCortney K, Horbinski CM, Stupp R, Zhang P, Ahmed AU, Sonabend AM, Heimberger AB, Lesniak MS, Riviere-Cazaux C, Burns T, Miska J, Fischietti M, Lee-Chang C. Wang S, et al. J Clin Invest. 2024 Aug 29;134(20):e177384. doi: 10.1172/JCI177384. J Clin Invest. 2024. PMID: 39207859 Free PMC article.
A Hitchhiker's Guide Toward CSF Biomarkers for Neuro-Oncology.
Riviere-Cazaux C, Keough MB, Zuccato JA, Kumar R, Schulz S, Warrington AE, Ruff MW, Ellingson BM, Sanai N, Campian JL, Kizilbash SH, Parney IF, Zadeh G, Khasraw M, Kessler T, Sener U, Cahill DP, Mansouri A, Burns TC. Riviere-Cazaux C, et al. Among authors: burns tc. Neuro Oncol. 2024 Dec 30:noae276. doi: 10.1093/neuonc/noae276. Online ahead of print. Neuro Oncol. 2024. PMID: 39786477
Deep learning MRI models for the differential diagnosis of tumefactive demyelination versus IDH-wildtype glioblastoma.
Conte GM, Moassefi M, Decker PA, Kosel ML, McCarthy CB, Sagen JA, Nikanpour Y, Fereidan-Esfahani M, Ruff MW, Guido FS, Pump HK, Burns TC, Jenkins RB, Erickson BJ, Lachance DH, Tobin WO, Eckel-Passow JE. Conte GM, et al. Among authors: burns tc. AJNR Am J Neuroradiol. 2025 Jan 9:ajnr.A8645. doi: 10.3174/ajnr.A8645. Online ahead of print. AJNR Am J Neuroradiol. 2025. PMID: 39788628
Proton versus photon craniospinal irradiation for adult medulloblastoma: A dosimetric, toxicity, and exploratory cost analysis.
Breen WG, Geno CS, Waddle MR, Qian J, Harmsen WS, Burns TC, Sener UT, Ruff MW, Neth BJ, Uhm JH, Routman DM, Yan E, Kruse JJ, Laack NN, Brown PD, Mahajan A. Breen WG, et al. Among authors: burns tc. Neurooncol Adv. 2024 Mar 8;6(1):vdae034. doi: 10.1093/noajnl/vdae034. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38550393 Free PMC article.
150 results